Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2015

Open Access 01-12-2015 | Research article

Association between arthritis score at the onset of the disease and long-term locomotor outcome in adjuvant-induced arthritis in rats

Authors: Claude Mossiat, Davy Laroche, Clément Prati, Thierry Pozzo, Céline Demougeot, Christine Marie

Published in: Arthritis Research & Therapy | Issue 1/2015

Login to get access

Abstract

Introduction

To investigate the connection between the intensity of initial symptoms of inflammation and locomotor outcome in rheumatoid arthritis, we examined the relationship between long-term locomotor abnormalities and signs of inflammation at the onset of the disease in adjuvant-induced arthritis (AIA) in rats.

Methods

The arthritis score and hind-paw diameter were followed from immunization to day 195 (~7 months). At this time, locomotion was recorded during forced treadmill walking using 3D motion technology before radiographic scoring of hind limb joint damage. Many locomotor parameters were analyzed including time and length parameters, limbs kinematics, lateral paw position at toe off, maximal hind-paw elevation and posture. Ankle mobility was assessed from range of motion (ROM) of the joint during locomotion. Experiments were run in AIA (n = 18) and age-matched non-AIA rats (n = 8).

Results

All AIA rats exhibited signs of inflammation at day 14 with a peak of inflammatory symptoms at day 22 post-immunization. After the first episode of inflammation, 83 % of AIA rats demonstrated recurrent disease (from week 6 to week 23). The frequency of inflammatory episodes (1 to 5) was not linked to the arthritis score at day 22. At day 195 post-immunization, AIA rats showed significantly impaired locomotion and radiographic lesions as compared to control rats. Significant relationships were observed between most locomotion-related parameters and concurrent ROM of ankle, which correlated negatively with the radiographic score. ROM of ankle at day 195 correlated negatively with both the arthritis score and hind-paw diameter measured at day 14, 22 and 30 post-immunization.

Conclusion

Decreased ankle mobility can be considered a driver of locomotion impairment in AIA. In this model, the severity of the initial inflammatory symptoms had a good prognostic value for long-term locomotor outcome.
Literature
1.
go back to reference Weiss RJ, Wretenberg P, Stark A, Palmblad K, Larsson P, Gröndal L, et al. Gait pattern in rheumatoid arthritis. Gait Posture. 2008;28:229–34.PubMedCrossRef Weiss RJ, Wretenberg P, Stark A, Palmblad K, Larsson P, Gröndal L, et al. Gait pattern in rheumatoid arthritis. Gait Posture. 2008;28:229–34.PubMedCrossRef
2.
go back to reference Dubbeldam R, Nene AV, Buurke JH, Groothuis-Oudshoorn CG, Baan H, Drossaers-Bakker KW, et al. Foot and ankle joint kinematics in rheumatoid arthritis cannot only be explained by alteration in walking speed. Gait Posture. 2011;33:390–5.PubMedCrossRef Dubbeldam R, Nene AV, Buurke JH, Groothuis-Oudshoorn CG, Baan H, Drossaers-Bakker KW, et al. Foot and ankle joint kinematics in rheumatoid arthritis cannot only be explained by alteration in walking speed. Gait Posture. 2011;33:390–5.PubMedCrossRef
3.
go back to reference Smulders E, Schreven C, van Lankveld W, Duysens J, Weerdesteyn V. Obstacle avoidance in persons with rheumatoid arthritis walking on a treadmill. Clin Exp Rheumatol. 2009;27:779–85.PubMed Smulders E, Schreven C, van Lankveld W, Duysens J, Weerdesteyn V. Obstacle avoidance in persons with rheumatoid arthritis walking on a treadmill. Clin Exp Rheumatol. 2009;27:779–85.PubMed
4.
go back to reference van der Leeden M, Steultjens MP, Ursum J, Dahmen R, Roorda LD, Schaardenburg DV, et al. Prevalence and course of forefoot impairments and walking disability in the first eight years of rheumatoid arthritis. Arthritis Rheum. 2008;59:1596–602.PubMedCrossRef van der Leeden M, Steultjens MP, Ursum J, Dahmen R, Roorda LD, Schaardenburg DV, et al. Prevalence and course of forefoot impairments and walking disability in the first eight years of rheumatoid arthritis. Arthritis Rheum. 2008;59:1596–602.PubMedCrossRef
5.
go back to reference Smolen JS, Aletaha D, Grisar J, Redlich K, Steiner G, Wagner O. The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now? Arthritis Res Ther. 2008;10:208.PubMedCentralPubMedCrossRef Smolen JS, Aletaha D, Grisar J, Redlich K, Steiner G, Wagner O. The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now? Arthritis Res Ther. 2008;10:208.PubMedCentralPubMedCrossRef
6.
go back to reference Nam JL, Winthrop KL, van Vollenhoven RF, Pavelka K, Valesini G, Hensor EM, et al. Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA. Ann Rheum Dis. 2010;69:976–86.PubMedCrossRef Nam JL, Winthrop KL, van Vollenhoven RF, Pavelka K, Valesini G, Hensor EM, et al. Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA. Ann Rheum Dis. 2010;69:976–86.PubMedCrossRef
7.
go back to reference Hegen M, Keith Jr JC, Collins M, Nickerson-Nutter CL. Utility of animal models for identification of potential therapeutics for rheumatoid arthritis. Ann Rheum Dis. 2008;67:1505–15.PubMedCrossRef Hegen M, Keith Jr JC, Collins M, Nickerson-Nutter CL. Utility of animal models for identification of potential therapeutics for rheumatoid arthritis. Ann Rheum Dis. 2008;67:1505–15.PubMedCrossRef
8.
go back to reference Bolon B, Stolina M, King C, Middleton S, Gasser J, Zack D, et al. Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy. J Biomed Biotechnol. 2011;2011:ID 569068.CrossRef Bolon B, Stolina M, King C, Middleton S, Gasser J, Zack D, et al. Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy. J Biomed Biotechnol. 2011;2011:ID 569068.CrossRef
9.
go back to reference Vincelette J, Xu Y, Zhang LN, Schaefer CJ, Vergona R, Sullivan ME, et al. Gait analysis in a murine model of collagen-induced arthritis. Arthritis Res Ther. 2007;9:R123.PubMedCentralPubMedCrossRef Vincelette J, Xu Y, Zhang LN, Schaefer CJ, Vergona R, Sullivan ME, et al. Gait analysis in a murine model of collagen-induced arthritis. Arthritis Res Ther. 2007;9:R123.PubMedCentralPubMedCrossRef
10.
go back to reference Coulthard P, Pleuvry BJ, Brewster M, Wilson KL, Macfarlane TV. Gait analysis as an objective measure in a chronic pain model. J Neurosci Methods. 2002;116:197–213.PubMedCrossRef Coulthard P, Pleuvry BJ, Brewster M, Wilson KL, Macfarlane TV. Gait analysis as an objective measure in a chronic pain model. J Neurosci Methods. 2002;116:197–213.PubMedCrossRef
11.
go back to reference Gabriel AF, Marcus MA, Honig WM, Walenkamp GH, Joosten EA. The CatWalk method: a detailed analysis of behavioral changes after acute inflammatory pain in the rat. J Neurosci Methods. 2007;163:9–16.PubMedCrossRef Gabriel AF, Marcus MA, Honig WM, Walenkamp GH, Joosten EA. The CatWalk method: a detailed analysis of behavioral changes after acute inflammatory pain in the rat. J Neurosci Methods. 2007;163:9–16.PubMedCrossRef
12.
go back to reference Ferreira-Gomes J, Adães S, Castro-Lopes JM. Assessment of movement-evoked pain in osteoarthritis by the knee-bend and CatWalk tests: a clinically relevant study. J Pain. 2008;9:945–54.PubMedCrossRef Ferreira-Gomes J, Adães S, Castro-Lopes JM. Assessment of movement-evoked pain in osteoarthritis by the knee-bend and CatWalk tests: a clinically relevant study. J Pain. 2008;9:945–54.PubMedCrossRef
13.
go back to reference Angeby Moller K, Berge OG, Hamers FP. Using the CatWalk method to assess weight-bearing and pain behaviour in walking rats with ankle joint monoarthritis induced by carrageenan: Effects of morphine and rofecoxib. J Neurosci Methods. 2008;174:1–9.PubMedCrossRef Angeby Moller K, Berge OG, Hamers FP. Using the CatWalk method to assess weight-bearing and pain behaviour in walking rats with ankle joint monoarthritis induced by carrageenan: Effects of morphine and rofecoxib. J Neurosci Methods. 2008;174:1–9.PubMedCrossRef
14.
go back to reference Hoffmann MH, Hopf R, Niederreiter B, Redl H, Smolen JS, Steiner G. Gait changes precede overt arthritis and strongly correlate with symptoms and histopathological events in pristane-induced arthritis. Arthritis Res Ther. 2010;12:R41.PubMedCentralPubMedCrossRef Hoffmann MH, Hopf R, Niederreiter B, Redl H, Smolen JS, Steiner G. Gait changes precede overt arthritis and strongly correlate with symptoms and histopathological events in pristane-induced arthritis. Arthritis Res Ther. 2010;12:R41.PubMedCentralPubMedCrossRef
15.
go back to reference Ferland CE, Laverty S, Beaudry F, Vachon P. Gait analysis and pain response of two rodent models of osteoarthritis. Pharmacol Biochem Behav. 2011;97:603–10.PubMedCrossRef Ferland CE, Laverty S, Beaudry F, Vachon P. Gait analysis and pain response of two rodent models of osteoarthritis. Pharmacol Biochem Behav. 2011;97:603–10.PubMedCrossRef
16.
go back to reference Parvathy SS, Masocha W. Gait analysis of C57BL/6 mice with complete Freund's adjuvant-induced arthritis using the CatWalk system. BMC Musculoskelet Disord. 2013;8:14:14. Parvathy SS, Masocha W. Gait analysis of C57BL/6 mice with complete Freund's adjuvant-induced arthritis using the CatWalk system. BMC Musculoskelet Disord. 2013;8:14:14.
17.
go back to reference Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S, et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature. 2003;426:454–60.PubMedCrossRef Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S, et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature. 2003;426:454–60.PubMedCrossRef
18.
go back to reference Esser RE, Hildebrand AR, Angelo RA, Watts LM, Murphey MD, Baugh LE. Measurement of radiographic changes in adjuvant-induced arthritis in rats by quantitative image analysis. Arthritis Rheum. 1995;38:129–38.PubMedCrossRef Esser RE, Hildebrand AR, Angelo RA, Watts LM, Murphey MD, Baugh LE. Measurement of radiographic changes in adjuvant-induced arthritis in rats by quantitative image analysis. Arthritis Rheum. 1995;38:129–38.PubMedCrossRef
19.
go back to reference Perrot O, Laroche D, Pozzo T, Marie C. Quantitative assessment of stereotyped and challenged locomotion after lesion of the striatum: a 3D kinematic study in rats. PLoS One. 2009;4:e7616.PubMedCentralPubMedCrossRef Perrot O, Laroche D, Pozzo T, Marie C. Quantitative assessment of stereotyped and challenged locomotion after lesion of the striatum: a 3D kinematic study in rats. PLoS One. 2009;4:e7616.PubMedCentralPubMedCrossRef
20.
go back to reference Perrot O, Laroche D, Pozzo T, Marie C. Kinematics of obstacle clearance in the rat. Behav Brain Res. 2011;224:241–9.PubMedCrossRef Perrot O, Laroche D, Pozzo T, Marie C. Kinematics of obstacle clearance in the rat. Behav Brain Res. 2011;224:241–9.PubMedCrossRef
21.
go back to reference Clarke KA, Parker AJ. A quantitative study of normal locomotion in the rat. Physiol Behav. 1986;38:345–51.PubMedCrossRef Clarke KA, Parker AJ. A quantitative study of normal locomotion in the rat. Physiol Behav. 1986;38:345–51.PubMedCrossRef
22.
go back to reference Filipe VM, Pereira JE, Costa LM, Mauricio AC, Couto PA, Melo-Pinto P, et al. Effect of skin movement on the analysis of hindlimb kinematics during treadmill locomotion in rats. J Neurosci Methods. 2006;153:55–61.PubMedCrossRef Filipe VM, Pereira JE, Costa LM, Mauricio AC, Couto PA, Melo-Pinto P, et al. Effect of skin movement on the analysis of hindlimb kinematics during treadmill locomotion in rats. J Neurosci Methods. 2006;153:55–61.PubMedCrossRef
23.
go back to reference Duhamel A, Bourriez JL, Devos P, Krystkowiak P, Destée A, Derambure P, et al. Statistical tools for clinical gait analysis. Gait Posture. 2004;20:204–12.PubMedCrossRef Duhamel A, Bourriez JL, Devos P, Krystkowiak P, Destée A, Derambure P, et al. Statistical tools for clinical gait analysis. Gait Posture. 2004;20:204–12.PubMedCrossRef
24.
go back to reference Carter JL, Lubahn C, Lorton D, Osredkar T, Der TC, Schaller J, et al. Adjuvant-induced arthritis induces c-Fos chronically in neurons in the hippocampus. J Neuroimmunol. 2011;230:85–94.PubMedCrossRef Carter JL, Lubahn C, Lorton D, Osredkar T, Der TC, Schaller J, et al. Adjuvant-induced arthritis induces c-Fos chronically in neurons in the hippocampus. J Neuroimmunol. 2011;230:85–94.PubMedCrossRef
25.
go back to reference Carl H-D, Putz C, Weseloh G, Forst R, Swoboda B. Insoles for the rheumatic foot. A clinical and pedobarographic analysis. Orthopade. 2006;35:1176–82.PubMedCrossRef Carl H-D, Putz C, Weseloh G, Forst R, Swoboda B. Insoles for the rheumatic foot. A clinical and pedobarographic analysis. Orthopade. 2006;35:1176–82.PubMedCrossRef
26.
go back to reference Grondal L, Tengstrand B, Nordmark B, Wretenberg P, Stark A. The foot: still the most important reason for walking incapacity in rheumatoid arthritis: distribution of symptomatic joints in 1,000 RA patients. Acta Orthop. 2008;79:257–61.PubMedCrossRef Grondal L, Tengstrand B, Nordmark B, Wretenberg P, Stark A. The foot: still the most important reason for walking incapacity in rheumatoid arthritis: distribution of symptomatic joints in 1,000 RA patients. Acta Orthop. 2008;79:257–61.PubMedCrossRef
27.
go back to reference Laroche D, Ornetti P, Thomas E, Ballay Y, Maillefert JF, Pozzo T. Kinematic adaptation of locomotor pattern in rheumatoid arthritis patients with forefoot impairment. Exp Brain Res. 2007;176:85–97.PubMedCrossRef Laroche D, Ornetti P, Thomas E, Ballay Y, Maillefert JF, Pozzo T. Kinematic adaptation of locomotor pattern in rheumatoid arthritis patients with forefoot impairment. Exp Brain Res. 2007;176:85–97.PubMedCrossRef
28.
go back to reference Moleanaar ET, Voskuyl AE, Dijkmans BA. Functional disability in relation to radiological damage and disease activity in patients with rheumatoid arthritis in remission. J Rheumatol. 2002;29:267–70. Moleanaar ET, Voskuyl AE, Dijkmans BA. Functional disability in relation to radiological damage and disease activity in patients with rheumatoid arthritis in remission. J Rheumatol. 2002;29:267–70.
29.
go back to reference Scott DL, Smith C, Kingsley G. Joint damage and disability in rheumatoid arthritis: an updated systematic review. Clin Exp Rheumatol. 2003;21:S30–27. Scott DL, Smith C, Kingsley G. Joint damage and disability in rheumatoid arthritis: an updated systematic review. Clin Exp Rheumatol. 2003;21:S30–27.
30.
go back to reference Bombardier C, Barbieri M, Parthan A, Zack DJ, Walker V, Macarios D, et al. The relationship between between joint damage and functional disability in rheumatoid arthritis : a systemic review. Ann Rheum Dis. 2012;71:836–44.PubMedCrossRef Bombardier C, Barbieri M, Parthan A, Zack DJ, Walker V, Macarios D, et al. The relationship between between joint damage and functional disability in rheumatoid arthritis : a systemic review. Ann Rheum Dis. 2012;71:836–44.PubMedCrossRef
31.
go back to reference Rauner M, Thiele S, Sinningen K, Winzer M, Salbach-Hirsch J, Gloe I, et al. Effects of the selective glucocorticoid receptor modulator compound A on bone metabolism and inflammation in male mice with collagen-induced arthritis. Endocrinology. 2013;154:3719–28.PubMedCrossRef Rauner M, Thiele S, Sinningen K, Winzer M, Salbach-Hirsch J, Gloe I, et al. Effects of the selective glucocorticoid receptor modulator compound A on bone metabolism and inflammation in male mice with collagen-induced arthritis. Endocrinology. 2013;154:3719–28.PubMedCrossRef
32.
go back to reference Abdin AA, Abd El-Halim MS, Hedeya SE, El-Saadany AA. Effect of atorvastatin with or without prednisolone on Freund's adjuvant induced-arthritis in rats. Eur J Pharmacol. 2012;676:34–40.PubMedCrossRef Abdin AA, Abd El-Halim MS, Hedeya SE, El-Saadany AA. Effect of atorvastatin with or without prednisolone on Freund's adjuvant induced-arthritis in rats. Eur J Pharmacol. 2012;676:34–40.PubMedCrossRef
33.
34.
go back to reference da Silva KN, Teixeira LE, Imoto AM, Atallah AN, Peccin MS, Trevisani VF. Effectiveness of sensorimotor training in patients with rheumatoid arthritis: a randomized controlled trial. Rheumatol Int. 2013;33:2269–75.PubMedCrossRef da Silva KN, Teixeira LE, Imoto AM, Atallah AN, Peccin MS, Trevisani VF. Effectiveness of sensorimotor training in patients with rheumatoid arthritis: a randomized controlled trial. Rheumatol Int. 2013;33:2269–75.PubMedCrossRef
36.
go back to reference Harris Jr ED, Emkey RD, Nichols JE, Newberg A. Low dose prednisone therapy in rheumatoid arthritis: a double blind study. J Rheumatol. 1983;10:713–21.PubMed Harris Jr ED, Emkey RD, Nichols JE, Newberg A. Low dose prednisone therapy in rheumatoid arthritis: a double blind study. J Rheumatol. 1983;10:713–21.PubMed
Metadata
Title
Association between arthritis score at the onset of the disease and long-term locomotor outcome in adjuvant-induced arthritis in rats
Authors
Claude Mossiat
Davy Laroche
Clément Prati
Thierry Pozzo
Céline Demougeot
Christine Marie
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2015
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/s13075-015-0700-8

Other articles of this Issue 1/2015

Arthritis Research & Therapy 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.